Insulin-stimulated AKT phosphorylation

There are 2 papers on insulin-stimulated AKT phosphorylation in aging research: 1 observational study in people, 1 in animals. The newest story, Nov 9, 2026: “Blood hormone adds to heart failure risk prediction in obesity”.

Biomarker

2 papers study it2 more mention it1 finding

1 new paper in 30 daysSee all 4 papers on insulin-stimulated AKT phosphorylation

  • Humans1
  • Animals1

Interventions

1

Endotrophin

downin human cells1

1 study
  1. Endotrophin decreases insulin-stimulated AKT phosphorylation in human cells (Insulin stimulation).

    “Recombinant ETP increased fibroinflammation and reduced insulin-stimulated AKT phosphorylation cell cultures, reversed by our anti-ETP monoclonal antibody.”

    CellsInsulin stimulationRecombinantLX-2 hepatic stellate cells and HSMM myoblasts

    Blood hormone adds to heart failure risk prediction in obesity

    AHA Scientific Sessions 2026 abstract

More on Endotrophin

Latest

Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 1Sep 2026: 0Oct 2026: 0Nov 2026: 12 papers in 12 months
AHA Scientific Sessions 2026 Abstract

Blood hormone adds to heart failure risk prediction in obesity

Over 13 years, heart failure developed in 9.69% of adults with obesity in the highest endotrophin group versus 3.12% in the lowest.Over 13 years, heart failure developed in 9.69% of adults with obesity in the highest endotrophin group versus 3.12% in the lowest.

Cohort · 7,728 peopleHeart failure